The most affordable option depends on your situation: 1
Diabetes, Obes Metab 19:4253
It's a non-invasive treatment with no surgery and no downtime, making it a great option for enhancing your results and boosting your confidence. Shape, Tighten & ToneNaturally with Neveskin
Typically, candidates for tirzepatide for weight loss include: Adults with a body mass index (BMI) of 30 kg/m or greater (classified as obesity) Adults with a BMI of 27 kg/m or greater who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol Tirzepatide is not intended for individuals with a personal or family history of medullary thyroid carcinoma, those with multiple endocrine neoplasia syndrome type 2, or anyone with a known hypersensitivity to the medication
For the full-year 2025 outlook, Novo Nordisk now expects sales growth of 8% to 14% at CER and operating profit growth of 10% to 16% at CER.